Clinical Trials on Bladder Urothelial Carcinoma
Total 25681 results
-
Genentech, Inc.Approved for marketing
-
Bristol-Myers SquibbCompletedUrothelial CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteEndo PharmaceuticalsCompletedUrothelial CarcinomaUnited States
-
Rambam Health Care CampusCompleted
-
National Taiwan University HospitalUnknownUrothelial CarcinomaTaiwan
-
China Medical University HospitalUnknown
-
China Medical University HospitalUnknown
-
Trans Tasman Radiation Oncology GroupNational Health and Medical Research Council, AustraliaCompletedTransitional Cell Carcinoma of Urinary BladderAustralia, New Zealand
-
Noah Hahn, M.D.Pfizer; Hoosier Cancer Research NetworkTerminatedTransitional Cell Carcinoma of the BladderUnited States, United Kingdom
-
Hoosier Cancer Research NetworkBristol-Myers SquibbCompletedTransitional Cell Carcinoma of the BladderUnited States
-
Chinese PLA General HospitalBeijing GeneX Health Technology Co., LtdRecruitingMuscle-Invasive Bladder CarcinomaChina
-
UroGen Pharma Ltd.CompletedCarcinoma of Urinary Bladder, SuperficialIsrael, Spain, Italy, Switzerland
-
Zetiq TechnologiesUnknownEvaluation Of Zetiq's Novel Cell Detect Technology For Detection Of Bladder Cancer In Urine CytologyBladder Cancer Transitional Cell CarcinomaIsrael
-
Zhongnan HospitalCompletedBladder Cancer | Urothelial CarcinomaChina
-
Case Comprehensive Cancer CenterPfizerTerminatedRecurrent Bladder Cancer | Transitional Cell Carcinoma of the BladderUnited States
-
UroGen Pharma Ltd.CompletedCarcinoma of Urinary Bladder, InvasiveIsrael
-
M.D. Anderson Cancer CenterCompletedBladder CancerUnited States
-
Sanjay Gandhi Postgraduate Institute of Medical...CompletedSurvival | Gall Bladder Carcinoma
-
National Cancer Institute (NCI)TerminatedBladder Carcinoma | Recurrent Bladder CarcinomaUnited States
-
Queen Mary University of LondonNot yet recruitingTransitional Cell Carcinoma | Bladder Cancer
-
Queen Mary University of LondonHoffmann-La RocheUnknownBladder CancerUnited Kingdom, France, Spain, Netherlands
-
Merck Sharp & Dohme LLCCompleted
-
National Cancer Institute (NCI)CompletedCarcinoma, Transitional Cell | Bladder NeoplasmsUnited States
-
Hopital FochCompleted
-
Oncolytics BiotechWithdrawnMuscle-invasive Transitional Cell Carcinoma of the Bladder
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedTransitional Cell Carcinoma of BladderItaly
-
First Affiliated Hospital of Zhejiang UniversityNot yet recruiting
-
Centre Francois BaclessePfizerRecruiting
-
University of MichiganCompletedBladder Cancer | Transitional Cell Carcinoma of the BladderUnited States
-
University of British ColumbiaRecruitingTransitional Cell Cancer of the Renal Pelvis and Ureter | Urothelial Carcinoma of the Renal Pelvis and UreterCanada
-
Fidia Farmaceutici s.p.a.CompletedONCOFID-P-B in the Intravescical Therapy of Patients With Non-muscle Invasive Cancer of the Bladder.Non-Invasive Papillary Carcinoma of BladderSpain, Germany, Italy
-
Princess Al-Johara Al-Ibrahim Cancer Research CenterCompletedTransitional Cell Carcinoma of the BladderSaudi Arabia
-
Emory UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Astellas Pharma Inc; Seagen...RecruitingStage III Bladder Cancer AJCC v8 | Stage IV Bladder Cancer AJCC v8 | Bladder Adenocarcinoma | Bladder Squamous Cell Carcinoma | Metastatic Bladder Carcinoma | Urachal Adenocarcinoma | Locally Advanced Bladder Carcinoma | Malignant Renal Pelvis Neoplasm | Malignant Ureter Neoplasm | Malignant Urethral Neoplasm and other conditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruitingHypospadias | Bladder, Neurogenic | Spina Bifida | Bladder Exstrophy | Urothelial Neoplasm
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.Active, not recruitingUrologic Neoplasms | Urinary Bladder Neoplasms | Carcinoma, Transitional Cell | Ureteral Neoplasms | Urothelial Cancer | Urethral Neoplasms | Renal Pelvis NeoplasmsUnited States, Italy, Spain, Canada, France, Puerto Rico
-
Astellas Pharma IncSeagen Inc.CompletedUrologic Neoplasms | Urinary Bladder Neoplasms | Carcinoma, Transitional Cell | Ureteral Neoplasms | Urothelial Cancer | Urethral Neoplasms | Renal Pelvis NeoplasmsUnited States, Korea, Republic of, Spain, France, Germany, Italy, Japan, Netherlands
-
Ruijin HospitalHangzhou Genetron Medical Laboratory Co., Ltd.Recruiting
-
Inovio PharmaceuticalsActive, not recruitingUrothelial CarcinomaUnited States, Spain
-
National Taiwan University HospitalUnknown
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingTransitional Cell Carcinoma | Metastatic Urothelial Carcinoma | Unresectable Transitional Cell CarcinomaUnited States
-
Erasmus Medical CenterMerck Sharp & Dohme LLCActive, not recruitingBiomarkers | Transitional Cell Carcinoma of the BladderNetherlands
-
Sichuan Baili Pharmaceutical Co., Ltd.RecruitingSolid Tumor | Urothelial CarcinomaChina
-
M.D. Anderson Cancer CenterRecruitingMetastatic MalignancyUnited States
-
Qinghua Xia,ProfNot yet recruiting
-
Guru P. SonpavdeQED Therapeutics, Inc.WithdrawnBladder Cancer | Bladder Transitional Cell Carcinoma | Fibroblast Growth Factor Receptor
-
Xinhua Hospital, Shanghai Jiao Tong University...Sun Yat-sen University; Shanghai Zhongshan Hospital; Southwest Hospital, China; Second Affiliated Hospital, School of Medicine, Zhejiang University and other collaboratorsUnknownCholangiocarcinoma | Gall Bladder Carcinoma | Biliary System DisorderChina
-
AstraZenecaCompletedPancreatic Ductal Adenocarcinoma | Triple-negative Breast Cancer | Urothelial Bladder CancerUnited States, Belgium, Korea, Republic of, Poland, Netherlands
-
Yale UniversityBayerCompleted